Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
60
FRAF Quote, Financials, Valuation and Earnings
Last price:
$48.18
Seasonality move
:
2.17%
Day range:
$47.57 - $49.80
52-week range:
$32.39 - $59.95
Dividend yield:
2.73%
P/E ratio:
10.20x
P/S ratio:
1.62x
P/B ratio:
1.24x
Volume:
34.3K
Avg. volume:
69.1K
1-year change:
32.35%
Market cap:
$216.7M
Revenue:
$133.5M
EPS (TTM):
$4.74
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $65.2M | $71.8M | $91.6M | $114.9M | $133.5M | |
| Revenue Growth (YoY) | 6.68% | 10.09% | 27.66% | 25.46% | 16.21% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $217K | -$160K | -$1.1M | -$4.1M | -- | |
| Operating Expenses | -$21.2M | -$17.5M | -$16.2M | -$13.3M | -$26.3M | |
| Operating Income | $21.2M | $17.5M | $16.2M | $13.3M | $26.3M | |
| Net Interest Expenses | $1M | $1M | $4.3M | $13M | -- | |
| EBT. Incl. Unusual Items | $23M | $17.5M | $15.8M | $13.3M | $26.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.4M | $2.6M | $2.2M | $2.2M | $5M | |
| Net Income to Company | $19.6M | $14.9M | $13.6M | $11.1M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $19.6M | $14.9M | $13.6M | $11.1M | $21.2M | |
| Basic EPS (Cont. Ops) | $4.44 | $3.38 | $3.11 | $2.52 | -- | |
| Diluted EPS (Cont. Ops) | $4.42 | $3.36 | $3.10 | $2.51 | $4.74 | |
| Weighted Average Basic Share | $4.4M | $4.4M | $4.4M | $4.4M | -- | |
| Weighted Average Diluted Share | $4.4M | $4.4M | $4.4M | $4.4M | -- | |
| EBITDA | $27.1M | $23.8M | $40.9M | $59.3M | -- | |
| EBIT | $25.9M | $22.4M | $38.9M | $57.3M | $71M | |
| Revenue (Reported) | $65.2M | $71.8M | $91.6M | $114.9M | $133.5M | |
| Operating Income (Reported) | $21.2M | $17.5M | $16.2M | $13.3M | $26.3M | |
| Operating Income (Adjusted) | $25.9M | $22.4M | $38.9M | $57.3M | $71M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $16.7M | $20.6M | $25.6M | $27.2M | $33.7M | |
| Revenue Growth (YoY) | 4.8% | 23.4% | 23.91% | 6.27% | 24.21% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $43K | -$80K | $41K | -$4.3M | -- | |
| Operating Expenses | -$4.2M | -$4.4M | -$4M | -$549K | -$7.5M | |
| Operating Income | $4.2M | $4.4M | $4M | $549K | $7.5M | |
| Net Interest Expenses | $261K | $260K | $1.7M | $2.5M | -- | |
| EBT. Incl. Unusual Items | $4.2M | $4.4M | $4M | $549K | $7.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $565K | $652K | $578K | $62K | $1.4M | |
| Net Income to Company | $3.7M | $3.7M | $3.5M | $487K | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $3.7M | $3.7M | $3.5M | $487K | $6M | |
| Basic EPS (Cont. Ops) | $0.82 | $0.85 | $0.80 | $0.11 | -- | |
| Diluted EPS (Cont. Ops) | $0.82 | $0.84 | $0.80 | $0.11 | $1.35 | |
| Weighted Average Basic Share | $4.4M | $4.4M | $4.4M | $4.4M | -- | |
| Weighted Average Diluted Share | $4.4M | $4.4M | $4.4M | $4.4M | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $4.9M | $6.8M | $11.7M | $12.3M | $17.9M | |
| Revenue (Reported) | $16.7M | $20.6M | $25.6M | $27.2M | $33.7M | |
| Operating Income (Reported) | $4.2M | $4.4M | $4M | $549K | $7.5M | |
| Operating Income (Adjusted) | $4.9M | $6.8M | $11.7M | $12.3M | $17.9M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $65.2M | $71.7M | $91.6M | $114.9M | $133.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $217K | -$160K | -$1.1M | -$4.1M | -- | |
| Operating Expenses | -$21.2M | -$17.5M | -$16.2M | -$13.3M | -$26.3M | |
| Operating Income | $21.2M | $17.5M | $16.2M | $13.3M | $26.3M | |
| Net Interest Expenses | $1.1M | $1M | $4.3M | $13M | $7.6M | |
| EBT. Incl. Unusual Items | $23M | $17.5M | $15.8M | $13.3M | $26.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.4M | $2.6M | $2.2M | $2.2M | $5M | |
| Net Income to Company | $19.6M | $14.9M | $13.6M | $11.1M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $19.6M | $14.9M | $13.6M | $11.1M | $21.2M | |
| Basic EPS (Cont. Ops) | $4.43 | $3.38 | $3.11 | $2.50 | -- | |
| Diluted EPS (Cont. Ops) | $4.41 | $3.36 | $3.10 | $2.49 | $4.74 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $25.9M | $22.4M | $38.9M | $57.3M | $71M | |
| Revenue (Reported) | $65.2M | $71.7M | $91.6M | $114.9M | $133.6M | |
| Operating Income (Reported) | $21.2M | $17.5M | $16.2M | $13.3M | $26.3M | |
| Operating Income (Adjusted) | $25.9M | $22.4M | $38.9M | $57.3M | $71M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $71.7M | $91.6M | $114.9M | $133.6M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$160K | -$1.1M | -$4.1M | -$7K | -- | |
| Operating Expenses | -$17.5M | -$16.2M | -$13.3M | -$26.3M | -- | |
| Operating Income | $17.5M | $16.2M | $13.3M | $26.3M | -- | |
| Net Interest Expenses | $1M | $4.3M | $13M | $7.6M | -- | |
| EBT. Incl. Unusual Items | $17.5M | $15.8M | $13.3M | $26.3M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.6M | $2.2M | $2.2M | $5M | -- | |
| Net Income to Company | $14.9M | $13.6M | $11.1M | $3.9M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $14.9M | $13.6M | $11.1M | $21.2M | -- | |
| Basic EPS (Cont. Ops) | $3.38 | $3.11 | $2.50 | $3.41 | -- | |
| Diluted EPS (Cont. Ops) | $3.36 | $3.10 | $2.49 | $4.74 | -- | |
| Weighted Average Basic Share | $17.7M | $17.5M | $17.8M | $13.4M | -- | |
| Weighted Average Diluted Share | $17.8M | $17.5M | $17.8M | $13.4M | -- | |
| EBITDA | $4.4M | $7.7M | $14.8M | $16.8M | -- | |
| EBIT | $22.4M | $38.9M | $57.3M | $71M | -- | |
| Revenue (Reported) | $71.7M | $91.6M | $114.9M | $133.6M | -- | |
| Operating Income (Reported) | $17.5M | $16.2M | $13.3M | $26.3M | -- | |
| Operating Income (Adjusted) | $22.4M | $38.9M | $57.3M | $71M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $10.5M | $17.9M | $19.5M | $19.8M | -- | |
| Short Term Investments | $529.8M | $486.8M | $472.5M | $319M | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $175.1M | $64.9M | $23.1M | $203.6M | -- | |
| Property Plant And Equipment | $23.9M | $36M | $33.2M | $33.1M | -- | |
| Long-Term Investments | $168M | $47.9M | $6.2M | $197.3M | -- | |
| Goodwill | $9M | $9M | $9M | $9M | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.8B | $1.7B | $1.8B | $2.2B | $2.2B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $130M | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $878.9M | $869.6M | $975.8M | $1.2B | -- | |
| Long-Term Debt | $23.8M | $24.9M | $23.8M | $223.3M | $200M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.6B | $1.6B | $1.7B | $2.1B | -- | |
| Common Stock | $4.7M | $4.7M | $4.7M | $4.7M | -- | |
| Other Common Equity Adj | -$547K | -$51.3M | -$40.9M | -$35.5M | -- | |
| Common Equity | $157.1M | $114.2M | $132.1M | $144.7M | $175.2M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $157.1M | $114.2M | $132.1M | $144.7M | $175.2M | |
| Total Liabilities and Equity | $1.8B | $1.7B | $1.8B | $2.2B | $175.2M | |
| Cash and Short Terms | $715.5M | $565.7M | $501.9M | $524.1M | -- | |
| Total Debt | $23.8M | $24.9M | $23.8M | $223.3M | $200M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $10.5M | $17.9M | $19.5M | $19.8M | -- | |
| Short Term Investments | $529.8M | $486.8M | $472.5M | $319M | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $175.1M | $64.9M | $23.1M | $203.6M | -- | |
| Property Plant And Equipment | $23.9M | $36M | $33.2M | $33.1M | -- | |
| Long-Term Investments | $168M | $47.9M | $6.2M | $197.3M | -- | |
| Goodwill | $9M | $9M | $9M | $9M | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.8B | $1.7B | $1.8B | $2.2B | $2.2B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $130M | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $878.9M | $869.6M | $975.8M | $1.2B | -- | |
| Long-Term Debt | $23.8M | $24.9M | $23.8M | $223.3M | $200M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.6B | $1.6B | $1.7B | $2.1B | -- | |
| Common Stock | $4.7M | $4.7M | $4.7M | $4.7M | -- | |
| Other Common Equity Adj | -$547K | -$51.3M | -$40.9M | -$35.5M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $157.1M | $114.2M | $132.1M | $144.7M | $175.2M | |
| Total Liabilities and Equity | $1.8B | $1.7B | $1.8B | $2.2B | $175.2M | |
| Cash and Short Terms | $715.5M | $565.7M | $501.9M | $524.1M | -- | |
| Total Debt | $23.8M | $24.9M | $23.8M | $223.3M | $200M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $12.8M | $19.6M | $14.9M | $13.6M | $11.1M | |
| Depreciation & Amoritzation | $1.3M | $1.2M | $1.4M | $2M | $2.1M | |
| Stock-Based Compensation | $197K | $204K | $462K | $483K | $634K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $13.8M | $19.7M | $22.7M | $26.5M | $24M | |
| Capital Expenditures | $1.5M | $8.8M | $12.2M | $499K | $2.6M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$284.7M | -$127.3M | -$92.5M | -$178.2M | -$186.6M | |
| Dividends Paid (Ex Special Dividend) | $5.2M | $5.5M | $5.7M | $5.6M | $5.6M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $19.5M | -- | -- | -- | $200M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | $1.2M | $1.2M | $3.3M | $2.4M | $827K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $244.2M | $225.6M | -$40.4M | $109.9M | $343.1M | |
| Beginning Cash (CF) | $83.8M | $57.1M | $175.1M | $64.9M | $23.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$26.7M | $118M | -$110.3M | -$41.8M | $180.5M | |
| Ending Cash (CF) | $57.1M | $175.1M | $64.9M | $23.1M | $203.6M | |
| Levered Free Cash Flow | $12.4M | $10.9M | $10.5M | $26M | $21.4M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.7M | $3.7M | $3.5M | $487K | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $43K | $110K | $117K | $169K | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.1M | $6.1M | $5.5M | $4.3M | -- | |
| Capital Expenditures | $1.4M | $1.2M | $20K | $383K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $34.2M | $3.7M | -$45.8M | -$87.9M | -- | |
| Dividends Paid (Ex Special Dividend) | $1.4M | $1.4M | $1.4M | $1.4M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -$110M | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | $90M | -- | |
| Repurchase of Common Stock | $88K | $670K | -- | $231K | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $39M | -$155.1M | -$10.6M | $50.9M | -- | |
| Beginning Cash (CF) | $98.9M | $210.2M | $74M | $236.3M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $76.3M | -$145.3M | -$50.8M | -$32.7M | -- | |
| Ending Cash (CF) | $175.1M | $64.9M | $23.1M | $203.6M | -- | |
| Levered Free Cash Flow | $1.6M | $4.9M | $5.5M | $3.9M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $19.6M | $14.9M | $13.6M | $11.1M | -- | |
| Depreciation & Amoritzation | $1.2M | $1.4M | $2M | $2.1M | -- | |
| Stock-Based Compensation | $204K | $462K | $483K | $634K | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $19.7M | $22.7M | $26.5M | $24M | -- | |
| Capital Expenditures | $8.8M | $12.2M | $499K | $2.6M | $882K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$127.3M | -$92.5M | -$178.2M | -$186.6M | -- | |
| Dividends Paid (Ex Special Dividend) | $5.5M | $5.7M | $5.6M | $5.6M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $200M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | $1.2M | $3.3M | $2.4M | $827K | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $225.6M | -$40.4M | $109.9M | $343.1M | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $118M | -$110.3M | -$41.8M | $180.5M | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $10.9M | $10.5M | $26M | $21.4M | -- | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $14.9M | $13.6M | $11.1M | $3.9M | -- | |
| Depreciation & Amoritzation | $267K | $479K | $538K | $537K | -- | |
| Stock-Based Compensation | $462K | $483K | $634K | $633K | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $22.7M | $26.5M | $24M | $22.3M | -- | |
| Capital Expenditures | $12.2M | $499K | $2.6M | $882K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$92.5M | -$178.2M | -$186.6M | -$112.1M | -- | |
| Dividends Paid (Ex Special Dividend) | $5.7M | $5.6M | $5.6M | $4.4M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $200M | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | $3.3M | $2.4M | $827K | $738K | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$40.4M | $109.9M | $343.1M | $74.4M | -- | |
| Beginning Cash (CF) | $757.3M | $290.2M | $621.8M | $203.6M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$110.3M | -$41.8M | $180.5M | -$15.5M | -- | |
| Ending Cash (CF) | $647M | $248.5M | $802.2M | $225M | -- | |
| Levered Free Cash Flow | $10.5M | $26M | $21.4M | $21.4M | -- | |
Get FRAF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
FRAF
Sector
P/E ratio
10.20x
12.54x
PEG ratio
0.11x
0.32x
P/B ratio
1.24x
1.15x
Price / LTM sales
1.62x
1.86x
Growth Metrics
FRAF
Sector
Revenue growth
24.21%
5.54%
Earnings growth
1127.27%
11.36%
Revenue (5-year growth)
16.93%
8.68%
Earnings forecast
--
$0.64
Profitability
FRAF
Sector
Profitability FY 2025
--
--
Return on invested capital
5.64%
5.2%
Return on assets
0.94%
1.03%
Return on equity
13.35%
9.91%
Earnings Date
Last Earnings Date
Jan
27
Next Earnings Date
Apr
28
Estimated Next Earnings Date
Apr
28
Balance Sheet
FRAF
Sector
Total cash
$531M
$407.2M
Short term investments
$319M
$192.4M
Total assets
$2.2B
$3.1B
Long term debt
$200M
$59.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
51
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Buy
75
PRLB alert for Feb 10
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
30
MSTR alert for Feb 10
Strategy, Inc. [MSTR] is up 2.59% over the past day.
Sell
10
MOH alert for Feb 10
Molina Healthcare, Inc. [MOH] is down 3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
